Cargando…
Liquid Biopsy Promotes Non-Small Cell Lung Cancer Precision Therapy
The range of potential applications of liquid biopsies for non-small cell lung cancer management is expanded by the use of circulating tumor deoxyribonucleic acid and circulating tumor cells. Principal studies have demonstrated the predictive accuracy of droplet digital polymerase chain reaction det...
Autores principales: | Lu, Jun, Han, Baohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153525/ https://www.ncbi.nlm.nih.gov/pubmed/30244652 http://dx.doi.org/10.1177/1533033818801809 |
Ejemplares similares
-
New Techniques in Understanding Cancer Biology and Metabolism
por: Biswas, Dipsikha, et al.
Publicado: (2020) -
Intra-cycle power: is the flow profile a neglected component of lung protection?
por: Marini, John J., et al.
Publicado: (2021) -
Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity
por: Mehta, Puja, et al.
Publicado: (2022) -
Application of liquid biopsy-based targeted capture sequencing analysis to improve the precision treatment of non-small cell lung cancer by tyrosine kinase inhibitors
por: Zhang, Lei, et al.
Publicado: (2022) -
Identification and validation of circulating exosomes‐based liquid biopsy for esophageal cancer
por: Zhao, An, et al.
Publicado: (2019)